ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The "test and treat" strategy for treating dyspeptic patients who are H. pylori positive is
rapidly becoming the standard of care. This study will test the effectiveness of RHB-105, a
new triple therapy to treat H. pylori infection in dyspeptic patients.